國家衛生研究院 NHRI:Item 3990099045/11049
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 857815      在线人数 : 836
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/11049


    题名: Role of academic institute in cancer therapy development in National Institute of Cancer Research, NHRI in Taiwan
    作者: Chen, LT
    贡献者: National Institute of Cancer Research
    摘要: National Health Research Institutes (NHRI) is a non-profit organization established by the Taiwan government in 1996. Among the 10 research units, 8 research institutes and two research centers, the National Institute of Cancer Research (NICR) and the Institute of Biotechnology and Pharmaceutical Research (IBPR) are involved in cancer therapy development. NICR aims to ascertain statistically efficacious new drugs and therapy for locally prevalent cancers through clinical trials. Whiles, IBPR is a fully integrated institute with multi-disciplinary technologies cover major aspects of the drug discovery and development. Such an integrated infrastructure facilitates the new drug development within NHRI. For instance, NICR joined in the pre-clinical and clinical development of a vascular-disrupting, anti-microtubular agent, DPRB104.Besides the intramural collaboration, NICR also plays an important role in helping the new drug development for domestic pharmaceutical companies. Regarding investigator-initiated trials, NICR explored the commercial available, off-labeled agents as well as yet approval agents for treating domestic prevalent cancers.
    日期: 2018-01
    關聯: Cancer Science. 2018 Jan;109(Suppl. 1):43.
    Link to: http://dx.doi.org/10.1111/cas.13499
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1347-9032&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000422694001077
    显示于类别:[陳立宗] 會議論文/會議摘要

    文件中的档案:

    档案 大小格式浏览次数
    ISI000422694001077.pdf44KbAdobe PDF144检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈